Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 4Dermatologic 2

Conditions

Skin Neoplasms 3Sarcoma, Kaposi 2Melanoma 2HIV Infections 2Squamous Cell Carcinoma of Head and Neck 1Neoplasms, Unknown Primary 1Nasopharyngeal Neoplasms 1Head and Neck Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Specimen Handling 3Magnetic Resonance Spectroscopy 3pembrolizumab 2Semaxinib 2Nivolumab 2Docetaxel 2tin etiopurpurin 1entinostat 1daromun 1cabozantinib 1Tumor Necrosis Factor-alpha 1Therapeutics 1Thalidomide 1SUB1 protein, human 1Ritonavir 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1Palliative Care 1Nutritional Support 1Nelfinavir 1Molecular Diagnostic Techniques 1Interleukin-12 1Immunotherapy 1Gemcitabine 1Filgrastim 1Drug Therapy 1Celecoxib 1Brentuximab Vedotin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma, Kaposi × Semaxinib × Dermatologic × Clear all
NCT00002226 2005-06-24

Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

NIH AIDS Clinical Trials Information Service

Phase NA Completed
30 enrolled
DermatologicSarcoma

Sarcoma, Kaposi, Skin Neoplasms, HIV Infections

NCT00005931 2005-06-24

SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment

NIH AIDS Clinical Trials Information Service

Phase 2 Completed
30 enrolled
DermatologicSarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Skin Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡